P704: ABERRANT IMMUNE MICROENVIRONMENT IN BONE MARROW OF MYELODYSPLASTIC SYNDROME PATIENTS DRIVES A SUPPRESSIVE PHENOTYPE

• Richa Rai,
• Foramben Patel,
• Jonathan Feld,
• Stella Melana,
• Erin Demakos,
• Amir Horowitz,
• Lewis Silevrman

Affiliations

Richa Rai

1 Icahn School of Medicine at Mount Sinai, Department of Hematology and Medical Oncology, New York, United States

Foramben Patel

1 Icahn School of Medicine at Mount Sinai, Department of Hematology and Medical Oncology, New York, United States

Jonathan Feld

1 Icahn School of Medicine at Mount Sinai, Department of Hematology and Medical Oncology, New York, United States

Stella Melana

1 Icahn School of Medicine at Mount Sinai, Department of Hematology and Medical Oncology, New York, United States

Erin Demakos

1 Icahn School of Medicine at Mount Sinai, Department of Hematology and Medical Oncology, New York, United States

Amir Horowitz

2 Lipshultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, Department of Oncological Science, New York, United States

Lewis Silevrman

1 Icahn School of Medicine at Mount Sinai, Department of Hematology and Medical Oncology, New York, United States